Biosynex SA (EPA:ALBIO)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Sale of Goods	42.94M	52.09M	99.36M	174.66M	109.83M
Sale of Goods Growth	-17.58%	-47.57%	-43.11%	59.03%	466.22%
Production Sold Goods	24.63M	15.39M	29.86M	44.06M	13.69M
Production Sold Goods Growth	60.00%	-48.44%	-32.25%	221.97%	0.37%
Production Sold Services	1.89M	2.37M	9.39M	18.58M	5.60M
Production Sold Services Growth	-20.40%	-74.72%	-49.48%	232.05%	367.09%
Unallocated Immobilised Production	911.00K	1.35M	672.00K	525.07K	302.06K
Unallocated Immobilised Production Growth	-32.47%	100.74%	27.98%	73.83%	12.93%
Unallocated Operating Grants	-	-	282.00K	435.83K	161.67K
Unallocated Operating Grants Growth	-	-	-35.30%	169.58%	17.64%
Total	70.36M	71.21M	139.55M	238.26M	129.57M
Total Growth	-1.19%	-48.97%	-41.43%	83.88%	274.11%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
France	52.82M	52.56M	120.20M	193.70M	109.80M
France Growth	0.50%	-56.27%	-37.95%	76.41%	337.45%
Export	48.35M	40.42M	76.40M	189.00M	44.10M
Export Growth	19.61%	-47.10%	-59.58%	328.57%	336.63%
Total	101.17M	92.98M	196.60M	382.70M	153.90M
Total Growth	8.81%	-52.71%	-48.63%	148.67%	337.22%

Source: S&P Global Market Intelligence.